0.18
+0.005(+2.89%)
Currency In USD
| Previous Close | 0.17 |
| Open | 0.18 |
| Day High | 0.19 |
| Day Low | 0.17 |
| 52-Week High | 79 |
| 52-Week Low | 0.13 |
| Volume | 6.62M |
| Average Volume | 5.66M |
| Market Cap | 4.56M |
| PE | 0 |
| EPS | -68.44 |
| Moving Average 50 Days | 0.26 |
| Moving Average 200 Days | 18.56 |
| Change | 0.01 |
If you invested $1000 in GlucoTrack, Inc. (GCTK) 10 years ago, it would be worth $0.02 as of May 01, 2025 at a share price of $0.173. Whereas If you bought $1000 worth of GlucoTrack, Inc. (GCTK) shares 5 years ago, it would be worth $0.3 as of May 01, 2025 at a share price of $0.173.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
GlobeNewswire Inc.
Apr 16, 2025 12:00 PM GMT
Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes studyRUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical de
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
GlobeNewswire Inc.
Apr 03, 2025 12:01 PM GMT
Next Generation AI-Driven Analytics to Unlock Key Insights from the Ongoing Continuous Blood Glucose Monitoring Clinical Study DataRUTHERFORD, N.J. and STOCKHOLM, April 03, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device
Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes
GlobeNewswire Inc.
Mar 19, 2025 12:01 PM GMT
Safety and performance data from direct blood glucose measurement technology to be featured at international diabetes technology conferenceRUTHERFORD, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device compan